7-Ethyl-10-Hydroxycamptothecin CAS 86639-52-3
Manufacturer Supple Irinotecan et intermedia:
Irinotecan hydrochloridum CAS: 100286-90-6
Irinotecan Free Base CAS: 97682-44-5
Irinotecan Hydrochloridis Trihydratorum CAS: 136572-09-3
7-Ethyl-10-Hydroxycamptothecinum CAS: 86639-52-3
1-Chlorocarbonyl-4-Piperidinopiperidium hydrochloridum CAS: 143254-82-4
Nomen chemicum | 7-Ethyl-10-Hydroxycamptothecin |
Synonyma | SN 38 |
CAS Number | 86639-52-3 |
CATTUS Number | RF-PI242 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C22H20N2O5 |
M. Pondus | 392.41 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Lux alba Crystalli pulveris |
Lepidium sativum (IR, UV) | (1) Absorptio spectri radius Ultraviolet iuxta postulata (2) Radius infrared effusio spectri concordans cum reference spectrum vexillum probatis probatis obtemperabit |
Liquescens punctum | 228.0~ 235.0℃ |
Substantiae cognatae | ≤1.5% |
10-Hydroxycamptothecin | ≤0.30% |
7-Cthylcamptothecin | ≤0.70% |
Maximum Ignotum immunditiam | ≤0.50% |
Damnum in Siccatio | ≤1.0% |
Metalla gravis | ≤10ppm |
Residere in Ignition | ≤0.10% |
Solutio in claritate | Patet |
Assay | ≥98.0% (HPLC) |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceuticum medium Irinotecan |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum 7-Ethyl-10-Hydroxycamptothecini (CAS: 86639-52-3) magna qualitate.7-Ethyl-10-Hydroxycamptothecin (CAS: 86639-52-3) metabolita activa est Topoisomerasi I inhibitoris Irinotecani.SN 38 (NK012) DNA et RNA synthesin cum IC, inhibet50s 0,077 et 1.3 µM, respective.7-Ethyl-10-Hydroxycamptothecin (SN 38), metabolita Irinotecani activa est, derivatio semisynthetica camptothecini, alkaloidis quinoline-substructio in cortice arboris camptothecae Sinicae et arbor nothapodytarum Asiatica.Etsi 7-Ethyl-10-Hydroxycamptothecinum usque ad 1,000 vicibus potentior est quam Irinotecan, tamen in candidatum viabile medicamento quia insolubile est, non est conversa.Statim subicitur iudiciis clinicis coniunctim cum aliis medietatibus quae tandem permittunt efficacem esse ut medicamentum antineoplasticum.